Satellos Bioscience Inc Com V.ICO

Active & deep pockets..

[eddy0505]

Have a feeling something coming down the pipe more then positive data report..more like business 

NEWS & EVENTS

 

 

Latest News

2018/07/09
WuXi Biologics and Immune Pharmaceuticals Announce Late-Phase Development and Manufacturing Partnership for a First-In-Class Monoclonal Antibody

2018/06/25
WuXi Biologics and Harbour BioMed Announce Strategic Development and Manufacturing Partnership

2018/06/20
WuXi Biologics Initiated Construction of a State-of-the-Art Integrated ADC Solution Center

2018/06/11
WuXi Biologics to Invest $60 Million to Establish a Biologics Production Facility in the United States

2018/05/30
WuXi Biologics and Tsinghua University Innovation Center for Immune Therapy Sign MOU and Announce Strategic Partnership

2018/05/22
WuXi Biologics to Invest S$80 Million to Establish a Biologics Manufacturing Facility in Singapore

2018/05/21
WuXi Biologics and Bioasis Announce Initial Strategic Collaboration for the Development and Manufacturing of Bioasis’ Lead Investigational Candidate to Treat Brain Cancer

2018/05/16
WuXi Biologics to Build an Integrated Biologics Development, Clinical and Commercial Manufacturing Center in Shijiazhuang

2018/05/14
WuXi Biologics Congratulates Aravive Biologics on Achieving Proof-of-Mechanism for Novel Biologic AVB-S6-500 within 20 Months from Cell Line Development

2018/04/30
WuXi Biologics to Invest €325 Million to Build Largest Biomanufacturing Facility Using Single-Use Bioreactors in Ireland

2018/04/17
WuXi Biologics Wins CMO Leadership Award from Life Science Leader Magazine

2018/03/21
WuXi Biologics to Install Industry’s Largest Single-Use Bioreactor from ABEC at its New Commercial Manufacturing Facility

2018/03/19
WuXi Biologics Reports Remarkable 2017 Annual Results: Revenue up 63.7% to a Record High of RMB1,618.8 Million

2018/03/09
WuXi Biologics and Adagene Announce Strategic Development and Manufacturing Partnership

2018/03/07
WuXi Biologics Congratulates TaiMed on FDA Approval for Trogarzo

2018/03/06
WuXi Biologics Receives Asia’s CMO of 2017 from BioPharma Industry Awards

2018/03/05
WuXi Biologics Announces Positive Profit Alert

2018/02/27
WuXi Biologics Congratulates MabSpace on FDA Clearance of IND for MSB2311

2018/02/13
WuXi Biologics Receives Two Bioprocessing Awards from IMAPAC

2018/02/09
WuXi Biologics Congratulates Tychan for Dosing First Patient of a Zika Antibody after Record 9 Months of Development

2018/01/31
WuXi Biologics Congratulates BioAtla on FDA Clearance of IND Application for CAB-AXL-ADC

2018/01/30
WuXi Biologics and Aravive Biologics to Form Strategic Manufacturing Collaboration Following Successful IND Filing for AVB-S6-500

2018/01/24